Concepts (66)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammation | 1 | 2025 | 1489 | 0.530 |
Why?
|
| Contraceptive Agents, Male | 1 | 2022 | 34 | 0.180 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2021 | 10 | 0.170 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2021 | 58 | 0.170 |
Why?
|
| Aurora Kinase A | 1 | 2021 | 37 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2022 | 129 | 0.170 |
Why?
|
| Gastrointestinal Diseases | 1 | 2024 | 343 | 0.170 |
Why?
|
| Drug Discovery | 1 | 2022 | 179 | 0.160 |
Why?
|
| Gene Amplification | 1 | 2021 | 219 | 0.160 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2021 | 54 | 0.160 |
Why?
|
| Incidence | 2 | 2025 | 3360 | 0.160 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 292 | 0.160 |
Why?
|
| Comorbidity | 1 | 2025 | 1595 | 0.160 |
Why?
|
| Eosinophils | 1 | 2021 | 122 | 0.160 |
Why?
|
| Reperfusion Injury | 1 | 2021 | 107 | 0.150 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2021 | 105 | 0.150 |
Why?
|
| Protein Kinases | 1 | 2021 | 312 | 0.150 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2025 | 650 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 588 | 0.130 |
Why?
|
| Receptors, Androgen | 1 | 2021 | 408 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 722 | 0.120 |
Why?
|
| Asthma | 1 | 2025 | 922 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 633 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 1211 | 0.120 |
Why?
|
| Proteins | 1 | 2021 | 1006 | 0.120 |
Why?
|
| Neuroblastoma | 1 | 2021 | 546 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 614 | 0.110 |
Why?
|
| Risk Factors | 2 | 2025 | 11074 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 2121 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1826 | 0.090 |
Why?
|
| Aged | 2 | 2025 | 21025 | 0.080 |
Why?
|
| Middle Aged | 2 | 2025 | 28601 | 0.070 |
Why?
|
| Adult | 2 | 2025 | 31282 | 0.060 |
Why?
|
| Male | 4 | 2025 | 64957 | 0.060 |
Why?
|
| New York City | 1 | 2024 | 59 | 0.050 |
Why?
|
| Humans | 7 | 2025 | 131163 | 0.050 |
Why?
|
| Mice | 4 | 2021 | 18301 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2021 | 2465 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 2026 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 3748 | 0.050 |
Why?
|
| Urban Population | 1 | 2024 | 287 | 0.050 |
Why?
|
| Female | 2 | 2025 | 70963 | 0.040 |
Why?
|
| Protein Domains | 1 | 2022 | 252 | 0.040 |
Why?
|
| Chloroquine | 1 | 2021 | 30 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 1410 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2022 | 552 | 0.040 |
Why?
|
| Interleukin-13 | 1 | 2021 | 97 | 0.040 |
Why?
|
| Animals | 4 | 2021 | 33912 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 235 | 0.040 |
Why?
|
| Cell Survival | 1 | 2021 | 826 | 0.040 |
Why?
|
| Prostate | 1 | 2021 | 404 | 0.030 |
Why?
|
| Gene Editing | 1 | 2021 | 238 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 1011 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 1591 | 0.030 |
Why?
|
| Autophagy | 1 | 2021 | 417 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2021 | 1571 | 0.030 |
Why?
|
| DNA | 1 | 2022 | 1399 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1827 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2323 | 0.020 |
Why?
|
| Liver | 1 | 2021 | 1796 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 3819 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5063 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4738 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4686 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17753 | 0.020 |
Why?
|
| Child | 1 | 2021 | 26341 | 0.010 |
Why?
|